Eris Lifesciences Q4FY23 Results: Consolidated PAT Drop to Rs 65.41 Cr
Eris Lifesciences Limited. Q4 results show revenue fell from 425.49 to 403.80 crores, a 5.10% decrease in growth. EPS also…
Eris Lifesciences Results
Read More